FDA Is Now Tracking Adverse Health Events Related To Hemp Cannabinoids Like CBD Following White House Approval

Marijuana Moment
By Kyle JaegerSep 30, 2025, 8:07 am144 ptsTrendingTop
The Food and Drug Administration (FDA) has updated its adverse drug event reporting forms to begin tracking incidents related to hemp-derived cannabinoid products such as CBD. The change to the federal documents—which are used by healthcare professionals, consumers and companies to report adverse experiences…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Study: Cannabis Extract An Effective Treatment For Chronic Back Pain 78

Wisconsin GOP Lawmakers Move to Legalize Medical Cannabis in 2025 75

Cannabis Stocks Surge After Trump Shares Video Promoting CBD Medicine 73

Trump Can Outdo Democrats By Rescheduling Marijuana When They Failed To Do So, Roger Stone Says 73

DataMatrix: A game-changer for cannabis supply chains 72

Colorado cannabis recalls affect record number of retailers in 2025 71

Simplifya Raises $2 Million in Equity Capital, Eliminates Debt, Expands Strategic Initiatives 70

LEEF Brands Launches New York Lab, 2025 Production Fully Committed 67

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.